Formulation, Optimization and In Vivo Evaluation of Fucoidan-Based Cream with Anti-Inflammatory Properties
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Fucoidan is a polysaccharide found in brown alga with glorious potential for pharmacological activities, among which its anti-inflammatory properties have gained meaningful attention. Due to several advantages of formulations for topical application, this study aimed to develop and optimize a fucoidan-based cream formulation and to investigate its anti-inflammatory potential after topical application in vivo. Fucoidan from Fucus vesiculosus L. was used. The cream base consisting of olive oil and Kolliphor RH40 was optimized followed by in vitro agar diffusion and drug release studies. The fucoidan-based cream with 13% Kolliphor P 407, 1% Transcutol P, and 5% PEG400 showed good spreadability, washability, and colloidal stability, and it did not irritate the skin. The kinetics of fucoidan release from the optimized cream exhibited the best fit to the Korsmeyer–Peppas and Higuchi models with R2 > 0.99. Fucoidan release was controlled by drug diffusion and anomalous transport provided by the optimized cream base. The formulation was stable and provided high fucoidan release after storage for 1 year. Topical application of the fucoidan-based cream dose-dependently inhibited carrageenan-induced edema and ameliorated mechanical allodynia in rats. The efficacy of the fucoidan-based cream at a high dose was comparable with the efficacy of diclofenac gel. The fucoidan-based cream could be considered a promising anti-inflammatory formulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509 · cited 1×
“Zero-order, first-order, Higuchi, Hixson–Crowell cube root law, and Korsmeyer– Peppas models [37,38] were tested to analyze the release mechanism of fucoidan.”
MethodChronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“Inflammation is attracting the attention of the global scientific community since it is involved in various human diseases [10].”
BackgroundChitosan-alginate biocomposite containing fucoidan for bone tissue engineering
Venkatesan, J., Bhatnagar, I., & Kim, S.-K. (2014) · Marine Drugs · doi:10.3390/md12010300 · Cited by 287
Therapies from Fucoidan: New Developments
Fitton, J. H., Stringer, D. N., Park, A. Y., & Karpiniec, S. S. (2019) · Marine Drugs · doi:10.3390/md17100571 · Cited by 225
Phull, A. R., & Kim, S. J. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.051 · Cited by 115
Jayawardena, T. U., Sanjeewa, K. K. A., Nagahawatta, D. P., Lee, H.-G., Lu, Y.-A., Vaas, A. P. J. P., Abeytunga, D. T. U., Nanayakkara, C. M., Lee, D.-S., & Jeon, Y.-J. (2020) · Marine Drugs · doi:10.3390/md18120601 · Cited by 80
The Pharmacokinetics of Fucoidan after Topical Application to Rats
Pozharitskaya, O. N., Shikov, A. N., Obluchinskaya, E. D., & Vuorela, H. (2019) · Marine Drugs · doi:10.3390/md17120687 · Cited by 79 · cited 1×
“The rationality of topical application of formulations with fucoidan was confirmed in our recent study [47], in which fucoidan was found in the skin, plasma, and striated muscles.”
BackgroundSelf-citation
Cited by
An Overview of Potential Seaweed-Derived Bioactive Compounds for Pharmaceutical Applications
Lomartire, S., & Gonçalves, A. M. M. (2022) · Marine Drugs · doi:10.3390/md20020141 · Cited by 272
Fucoidan in pharmaceutical formulations: A comprehensive review for smart drug delivery systems
Haggag, Y., Abd Elrahman, A., Ulber, R., & Zayed, A. (2023) · Marine Drugs · doi:10.3390/md21020112 · Cited by 126
“On the contrary, the formulation containing DMSO showed the slowest release and the poorest spreadability [79].”
BackgroundIn Vitro Anti-Inflammatory Activities of Fucoidans from Five Species of Brown Seaweeds
Obluchinskaya, E. D., Pozharitskaya, O. N., & Shikov, A. N. (2022) · Marine Drugs · doi:10.3390/md20100606 · Cited by 113
Self-citationThe Biochemical Composition and Antioxidant Properties of Fucus vesiculosus from the Arctic Region
Obluchinskaya, E. D., Pozharitskaya, O. N., Zakharov, D. V., Flisyuk, E. V., Terninko, I. I., Generalova, Y. E., Smekhova, I. E., & Shikov, A. N. (2022) · Marine Drugs · doi:10.3390/md20030193 · Cited by 87
Self-citationNagahawatta, D. P., Liyanage, N. M., Jayawardhana, H. H. A. C. K., Lee, H.-G., Jayawardena, T., & Jeon, Y.-J. (2022) · Marine Drugs · doi:10.3390/md20070413 · Cited by 43
“Several previous studies have reported the anti-inflammatory activity of fucoidan in different experimental models, including in vitro and in vivo, such as developing an anti-inflammatory lotion using fucoidan isolated from Fucus vesiculosus [25,26], anti-colon-tumor effects, anti-breast-cancer effects, and anti-lung-…”
Background
Metadata
- Authors
- Obluchinskaya, E. D., Pozharitskaya, O. N., Flisyuk, E. V., & Shikov, A. N.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2021-11-17
- Volume
- 19
- Issue
- 11
- Pages
- 643
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W3213609052
- Cited by
- 56
- References
- 7
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Formulation, Optimization and In Vivo Evaluation of Fucoidan-Based Cream with Anti-Inflammatory Properties. https://app.cochat.ai/papers/10.3390/md19110643
- The paper
- Obluchinskaya, E. D., Pozharitskaya, O. N., Flisyuk, E. V., & Shikov, A. N. (2021). Formulation, Optimization and In Vivo Evaluation of Fucoidan-Based Cream with Anti-Inflammatory Properties. Marine Drugs. https://doi.org/10.3390/md19110643
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.